Last reviewed · How we verify
NCT06614868: MST
Minority Stress Counseling for LGBTQ+ Individuals
NA trial testing Acceptance and Commitment Therapy in Minority Stress in 80 participants. Currently enrolling.
1 August 2026
Quick facts
| Lead sponsor | University of Alabama at Birmingham |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 15 January 2025 |
| Primary completion | 1 August 2026 |
| Estimated completion | 15 August 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Acceptance and Commitment Therapy
- Treatment as Usual (TAU) — full drug profile →
Conditions studied
- Minority Stress — all drugs for Minority Stress →
Sponsor
University of Alabama at Birmingham
Who can join
18 and older, any sex, with Minority Stress. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Lesbian, gay, bisexual, transgender, and queer+ (LGBTQ+) individuals experience a breadth of mental health disparities. Reducing these disparities is an area of key psychological research. Minority stress is theorized to be an underlying source of the disparities (Meyer, 2003). Minority stress can be conceptualized as the internalized stigma that results from experiences of social marginalization. By reducing minority stress, it is hypothesized that generalized mental illness indicators might be reduced and indicators of wellbeing increased.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06614868
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Acceptance and Commitment Therapy
Trials testing the same drug.
- NCT07397195 — ACT for Veterans With IBD and Mental Health Challenges · NA · not yet recruiting
- NCT07345806 — A Pilot Study on an ACT-Based Program for Individuals With Special Needs and Their Caregivers · NA · recruiting
- NCT07512388 — Acceptance and Commitment Therapy for Post-Stroke Adjustment Via Telerehabilitation · NA · active not recruiting
- NCT06647589 — Acceptance and Commitment Therapy for Religious OCD · NA · recruiting
- NCT06971861 — Just ACT for Student Well-being · NA · recruiting
Other recruiting trials for Minority Stress
Currently open trials in the same condition.
- NCT07326748 — Lakota Family Acceptance Project · NA · recruiting
Other University of Alabama at Birmingham trials
Trials by the same sponsor.
- NCT04922229 — Comparative Effectiveness in the Management of Irreversible Pulpitis · NA · not yet recruiting
- NCT05060380 — Feasibility of a Novel Resistance Exercise in Individuals With Osteoporosis · NA · withdrawn
- NCT04768777 — Behavioral Intervention for Physical Activity and Sexual Dysfunction in Multiple Sclerosis · NA · not yet recruiting
- NCT06320951 — VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine · Phase 2 · not yet recruiting
- NCT07564934 — Leveraging Extended Reality Exergaming and Telehealth to Improve Physical Activity and Health in Children With Disabilit · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06614868 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Alabama at Birmingham
- Last refreshed: 11 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06614868.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing